Skip to main content

SkinHealth Systems Inc. (SKIN) Stock Forecast

Data as of Sep 16, 2026

Healthcare · Current price $0.67 (-0.53%)

Consensus Target
$1.50
Upside
+112.8%
Analysts
3
Rating
Hold(2.67)

Price Target Range

Low $1.00Consensus $1.50High $2.00
▲ Current $0.67

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

Consensus
Hold
Strong Buy0
Buy0
Hold1
Sell0
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

DateAnalystFirmPrice TargetUpside
Sep 19, 2025George KellyRoth Capital$3.50+421.3%
May 5, 2025Susan AndersonCanaccord Genuity$1.25+86.2%
Aug 9, 2024Korinne WolfmeyerPiper Sandler$1.00+48.9%
May 10, 2024Korinne WolfmeyerPiper Sandler$2.50+272.4%
Mar 13, 2024Korinne WolfmeyerPiper Sandler$3.00+346.8%
Mar 13, 2024Jonathan BlockStifel Nicolaus$4.00+495.8%

SKIN vs Sector & Market

MetricSKINHealthcare AvgLarge Cap Avg
Analyst Rating2.672.252.42
Analyst Count3818
Target Upside+112.8%+16187.1%+19.5%
P/E Ratio-11.193.8038.67

Revenue Estimates

PeriodLowAvgHigh#
2026-09-30$70M$71M$73M4
2026-12-31$82M$83M$84M5
2027-03-31$68M$69M$70M3
2027-06-30$78M$79M$80M3
2027-09-30$72M$73M$75M3
2027-12-31$85M$86M$88M3
2028-12-31$322M$322M$322M3

EPS Estimates

PeriodLowAvgHigh#
2026-09-30$-0.05$-0.05$-0.051
2026-12-31$-0.01$-0.01$-0.011
2027-03-31$-0.06$-0.06$-0.051
2027-06-30$-0.04$-0.04$-0.031
2027-09-30$-0.06$-0.06$-0.061
2027-12-31$-0.04$-0.04$-0.031
2028-12-31$-0.16$-0.14$-0.123

Frequently Asked Questions

What is the analyst consensus for SKIN?

The consensus among 3 analysts covering SkinHealth Systems Inc. (SKIN) is Hold with an average price target of $1.50.

What is the highest price target for SKIN?

The highest price target for SKIN is $4.00, set by Jonathan Block at Stifel Nicolaus on 2024-03-13.

What is the lowest price target for SKIN?

The lowest price target for SKIN is $1.00, set by Korinne Wolfmeyer at Piper Sandler on 2024-08-09.

How many analysts cover SKIN?

3 analysts have issued ratings for SkinHealth Systems Inc. in the past 12 months.

Is SKIN a buy or sell right now?

Based on 3 analyst ratings, SKIN has a consensus rating of Hold (2.67/5) with a +112.8% upside to the consensus target of $1.50.

What are the earnings estimates for SKIN?

Analysts estimate SKIN will report EPS of $-0.05 for the period ending 2026-09-30, with revenue estimated at $71M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.